一种治疗非酒精性脂肪性肝病的中药组合物及其制剂和应用
By using a combination of traditional Chinese medicine to regulate spleen and stomach function and promote blood circulation, this approach solves the treatment challenges of non-alcoholic fatty liver disease, significantly improves liver function and metabolic indicators, and provides a safe and effective treatment option.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
- Filing Date
- 2024-05-30
- Publication Date
- 2026-07-17
AI Technical Summary
Current technologies are insufficient to effectively treat non-alcoholic fatty liver disease (NAFLD), especially its advanced stage, non-alcoholic steatohepatitis (NASH), which can lead to liver fibrosis, cirrhosis, and liver cancer. Furthermore, existing drug treatments have limited efficacy and significant side effects.
A traditional Chinese medicine composition is used, consisting of Salvia miltiorrhiza, Atractylodes macrocephala, Poria cocos, prepared licorice root, Sedum sarmentosum, Lonicera japonica, Fritillaria thunbergii, Crataegus pinnatifida, chicken gizzard lining, Bupleurum chinense, and mulberry leaf. It is prepared by decoction and taken in the form of soup, granules, powder, capsules, or oral liquid to regulate spleen and stomach function, promote blood circulation and remove blood stasis, clear heat and detoxify, and improve liver function.
It significantly improves hepatocellular steatosis, reduces intracellular TC and TG levels, decreases the expression of inflammatory factors, improves liver function indicators, reduces liver fat content, and improves glucose and lipid metabolism, with good safety and few side effects.
Smart Images
Figure CN118542911B_ABST